These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
342 related articles for article (PubMed ID: 26598518)
1. Regulation of c-Myc Expression by Ahnak Promotes Induced Pluripotent Stem Cell Generation. Lim HJ; Kim J; Park CH; Lee SA; Lee MR; Kim KS; Kim J; Bae YS J Biol Chem; 2016 Jan; 291(2):752-61. PubMed ID: 26598518 [TBL] [Abstract][Full Text] [Related]
2. Generation of induced pluripotent stem cells from buffalo (Bubalus bubalis) fetal fibroblasts with buffalo defined factors. Deng Y; Liu Q; Luo C; Chen S; Li X; Wang C; Liu Z; Lei X; Zhang H; Sun H; Lu F; Jiang J; Shi D Stem Cells Dev; 2012 Sep; 21(13):2485-94. PubMed ID: 22420535 [TBL] [Abstract][Full Text] [Related]
3. Optimization of reprogramming culture conditions for the generation of induced pluripotent stem cells from Col1a1 4F2A-Oct4-GFP mice with high efficiency. Lin PY; Hsu SC; Chen HC; Len WB; Hsiao FC; Liu MC; Pan PL; Lin TC; Lee YH; Meir YJ FEBS J; 2018 May; 285(9):1667-1683. PubMed ID: 29575491 [TBL] [Abstract][Full Text] [Related]
4. High-efficiency generation of induced pluripotent mesenchymal stem cells from human dermal fibroblasts using recombinant proteins. Chen F; Zhang G; Yu L; Feng Y; Li X; Zhang Z; Wang Y; Sun D; Pradhan S Stem Cell Res Ther; 2016 Jul; 7(1):99. PubMed ID: 27473118 [TBL] [Abstract][Full Text] [Related]
5. Enhanced human somatic cell reprogramming efficiency by fusion of the MYC transactivation domain and OCT4. Wang L; Huang D; Huang C; Yin Y; Vali K; Zhang M; Tang Y Stem Cell Res; 2017 Dec; 25():88-97. PubMed ID: 29125994 [TBL] [Abstract][Full Text] [Related]
6. Increased efficiency in the generation of induced pluripotent stem cells by Fbxw7 ablation. Okita Y; Matsumoto A; Yumimoto K; Isoshita R; Nakayama KI Genes Cells; 2012 Sep; 17(9):768-77. PubMed ID: 22897623 [TBL] [Abstract][Full Text] [Related]
7. Generation of disease-specific induced pluripotent stem cells from patients with different karyotypes of Down syndrome. Mou X; Wu Y; Cao H; Meng Q; Wang Q; Sun C; Hu S; Ma Y; Zhang H Stem Cell Res Ther; 2012 Apr; 3(2):14. PubMed ID: 22512921 [TBL] [Abstract][Full Text] [Related]
8. Generation of human induced pluripotent stem cell line UNIGEi001-A from a 2-years old patient with Mucopolysaccharidosis type IH disease. Lito S; Burda P; Baumgartner M; Sloan-Béna F; Táncos Z; Kobolák J; Dinnyés A; Krause KH; Marteyn A Stem Cell Res; 2019 Dec; 41():101604. PubMed ID: 31678774 [TBL] [Abstract][Full Text] [Related]
9. Successful Derivation of an Induced Pluripotent Stem Cell Line from a Genetically Nonpermissive Enhanced Green Fluorescent Protein-Transgenic FVB/N Mouse Strain. Abbey D; Singh G; Verma I; Derebail S; Kolkundkar U; Chandrashekar DS; Acharya KK; Vemuri MC; Seshagiri PB Cell Reprogram; 2019 Oct; 21(5):270-284. PubMed ID: 31596624 [TBL] [Abstract][Full Text] [Related]
10. Reprogramming induced pluripotent stem cells in the absence of c-Myc for differentiation into hepatocyte-like cells. Li HY; Chien Y; Chen YJ; Chen SF; Chang YL; Chiang CH; Jeng SY; Chang CM; Wang ML; Chen LK; Hung SI; Huo TI; Lee SD; Chiou SH Biomaterials; 2011 Sep; 32(26):5994-6005. PubMed ID: 21658760 [TBL] [Abstract][Full Text] [Related]